BofA/Merrill Lynch Maintains Bullish View on Community Health (CYH) Despite Guidance Reduction

BofA/Merrill Lynch analyst Kevin Fischbeck reiterated a Buy rating and $72 price target on Community Health (NYSE: CYH) following Q3 results which beat as volumes improved but guidance was reduced on deals timing.

Fischbeck comments, "While the guidance reduction is somewhat disappointing given the improving core and higher synergies, we note Q4 EBITDA guidance looks quite achievable and implies upside to 2015 consensus EBITDA. We also note the expectations for CYH were low as consensus was already at the low end of the guidance range for the year. CYH remains our top pick as we continue to see the biggest upside from Reform and the continued improvement in the core business."

For an analyst ratings summary and ratings history on Community Health click here. For more ratings news on Community Health click here.

Shares of Community Health closed at $55.43 yesterday.

You May Also Be Interested In

• Community Health (CYH) PT Lowered to $4.50 at Oppenheimer
• Assa Abloy (ASSAB:SS) (ASAZY) PT Raised to SEK275 at Citi
• Temenos AG (TEMN:SW) (TMSNY) PT Lowered to CHF65 at Citi